Portal de Periódicos da CAPES

Current Management of the Hemophilic Child: A Demanding Interlocutor. Quality of Life and Adequate Cost-Efficacy Analysis

2014; Taylor & Francis; Volume: 31; Issue: 8 Linguagem: Inglês

10.3109/08880018.2014.930768

1521-0669

Paola Giordano, Giuseppe Lassandro, Michele Valente, Angelo Claudio Molinari, P. Ieranò, Antonio Coppola,

Coagulation, Bradykinin, Polyphosphates, and Angioedema

Hemophilias are the most known inherited bleeding disorders. The challenges in the management of hemophilic children are different from those in adults: prophylaxis regimen removed the hallmark of crippling disease with lifelong disabilities; individualized regimens are being implemented in order to overcome venous access problems. Presently, at least in high-income countries, advances in treatment of hemophilia resulted in continuous improvement of the patients' quality of life and life expectancy. Inhibitors remain the most severe complication of hemophilia therapy. The treatment' compliance is the key to achieve a successful management. The patient, his family, the medical and psychological team are the players of a comprehensive care system. The current management of hemophilic children is the example of huge resource investments enabling long-term benefits in particular quality of life as a primary objective of the healthcare process.